Intended Use

The ClearPoint System is intended to provide stereotactic guidance for neurological procedures within the MRI environment, including automatic identification, labeling, visualization, and quantification of brain structures from MRI images, used during biopsies and deep brain stimulation lead placement.

Technology

ClearPoint System Software Version 2.2 integrates ClearPoint Neuro Maestro Brain Model software to enable automatic segmentation and visualization of brain structures. It includes a workstation laptop, SMARTGrid MRI-Guided Planning Grid, SMARTFrame MRI-Guided Trajectory Frame, and accessories for neurosurgical guidance. It operates with 1.5 and 3.0 Tesla MRI scanners, supports Windows 10/11 OS, and features image registration, 3D visualization, and measurement tools.

Performance

Software verification testing included automated verification, integrated system verification, localization verification, regression test verification, and manual testing, all meeting acceptance criteria. Accuracy testing confirmed that software modifications did not adversely affect system accuracy, with positional errors under 1.5 mm and angular errors below 0.5 degrees.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/28/2023

    2 months
  • 2

    FDA Approval

    11/27/2023

Other devices from ClearPoint Neuro Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.